Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors
Article in Psychiatry Research (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Assessment of Innovative Pharmacological Targets in Schizophrenia
Article in Current Treatment Options in Psychiatry (July 2024)
New drug treatments for schizophrenia: a review of approaches to target circuit dysfunction
Article in Biological Psychiatry (May 2024)